Pin Oak Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $584K | Buy |
24,253
+17
| +0.1% | +$445 | 0.42% | 52 |
|
|
2026
Q1 | $681K | Sell |
24,236
-308
| -1% | -$8.2K | 0.48% | 46 |
|
|
2025
Q4 | $679K | Buy |
24,544
+537
| +2% | +$13.5K | 0.48% | 46 |
|
|
2025
Q3 | $612K | Sell |
24,007
-2,365
| -9% | -$58.4K | 0.44% | 47 |
|
|
2025
Q2 | $668K | Sell |
26,372
-906
| -3% | -$21.1K | 0.57% | 38 |
|
|
2025
Q1 | $691K | Sell |
27,278
-1,704
| -6% | -$44.6K | 0.53% | 40 |
|
|
2024
Q4 | $839K | Hold |
28,982
| – | – | 0.76% | 28 |
|
|
2024
Q3 | $838K | Buy |
28,982
+143
| +0.5% | +$4.17K | 0.76% | 28 |
|
|
2024
Q2 | $807K | Sell |
28,839
-165
| -0.6% | -$4.54K | 0.77% | 28 |
|
|
2024
Q1 | $805K | Sell |
29,004
-540
| -2% | -$15K | 0.77% | 30 |
|
|
2023
Q4 | $851K | Sell |
29,544
-4,200
| -12% | -$127K | 0.86% | 26 |
|
|
2023
Q3 | $1.12M | Buy |
33,744
+9,050
| +37% | +$320K | 1.26% | 16 |
|
|
2023
Q2 | $906K | Sell |
24,694
-470
| -2% | -$18.3K | 1% | 23 |
|
|
2023
Q1 | $1.03M | Buy |
25,164
+895
| +4% | +$38.7K | 1.27% | 18 |
|
|
2022
Q4 | $1.24M | Sell |
24,269
-175
| -0.7% | -$8.39K | 1.53% | 16 |
|
|
2022
Q3 | $1.07M | Hold |
24,444
| – | – | 1.34% | 18 |
|
|
2022
Q2 | $1.28M | Sell |
24,444
-778
| -3% | -$39.6K | 1.57% | 14 |
|
|
2022
Q1 | $1.31M | Sell |
25,222
-1,075
| -4% | -$55.8K | 1.4% | 17 |
|
|
2021
Q4 | $1.55M | Sell |
26,297
-13,768
| -34% | -$682K | 1.57% | 20 |
|
|
2021
Q3 | $1.72M | Sell |
40,065
-175
| -0.4% | -$7.75K | 1.9% | 17 |
|
|
2021
Q2 | $1.58M | Sell |
40,240
-850
| -2% | -$33.1K | 1.6% | 19 |
|
|
2021
Q1 | $1.49M | Sell |
41,090
-296
| -0.7% | -$10.5K | 1.27% | 29 |
|
|
2020
Q4 | $1.52M | Sell |
41,386
-2,190
| -5% | -$80.3K | 1.25% | 27 |
|
|
2020
Q3 | $1.52M | Sell |
43,576
-4,811
| -10% | -$169K | 1.46% | 20 |
|
|
2020
Q2 | $1.5M | Sell |
48,387
-3,106
| -6% | -$106K | 1.39% | 24 |
|
|
2020
Q1 | $1.59M | Sell |
51,493
-6,968
| -12% | -$237K | 1.67% | 14 |
|
|
2019
Q4 | $2.17M | Sell |
58,461
-2,767
| -5% | -$98.6K | 1.75% | 17 |
|
|
2019
Q3 | $2.09M | Buy |
61,228
+48
| +0.1% | +$1.75K | 1.71% | 15 |
|
|
2019
Q2 | $2.52M | Sell |
61,180
-2,267
| -4% | -$90K | 1.96% | 10 |
|
|
2019
Q1 | $2.56M | Sell |
63,447
-1,909
| -3% | -$76.5K | 2.05% | 10 |
|
|
2018
Q4 | $2.71M | Sell |
65,356
-2,453
| -4% | -$102K | 2.4% | 5 |
|
|
2018
Q3 | $2.83M | Sell |
67,809
-4,713
| -6% | -$181K | 2.13% | 9 |
|
|
2018
Q2 | $2.5M | Sell |
72,522
-4,602
| -6% | -$157K | 1.83% | 15 |
|
|
2018
Q1 | $2.6M | Sell |
77,124
-1,518
| -2% | -$52.2K | 2.1% | 10 |
|
|
2017
Q4 | $2.7M | Buy |
+78,642
| New | +$2.68M | 2.07% | 8 |
|
Other funds holding PFE
Pin Oak Investment Advisors's PFE Position: Q2 2026 in Review
Pin Oak Investment Advisors increased its Pfizer (PFE) stake by 0.07% in Q2 2026, buying an estimated $445 and bringing the position to 24,253 shares worth $584K. The position accounts for 0.42% of the portfolio, ranked #52.
Pin Oak Investment Advisors first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.83M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Pin Oak Investment Advisors held 24,253 shares of Pfizer worth $584K as of Q2 2026.
- Pin Oak Investment Advisors bought 17 Pfizer shares in Q2 2026, an estimated $445.
- Pfizer made up 0.42% of Pin Oak Investment Advisors's portfolio in Q2 2026, its #52 holding.
- Pin Oak Investment Advisors first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Pin Oak Investment Advisors's Pfizer position peaked at $2.83M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Pin Oak Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.